Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani
- PMID: 12559811
- DOI: 10.1016/s0264-410x(02)00352-3
Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani
Abstract
The gene ORFF is part of the multigenic LD1 locus on chromosome 35 that is frequently amplified in Leishmania. The function of ORFF is unknown. The gene encoding ORFF was cloned into a eukaryotic expression vector downstream to the cytomegalovirus (CMV) promoter. BALB/c mice were injected intramuscularly with ORFF DNA and challenged with Leishmania donovani promastigotes. Vaccination with ORFF gene induced both humoral and cellular immune response against ORFF, which provided significant level of protection against challenge with L. donovani. A qualitative PCR was used to determine whether activation of Th1 cells develops selectively in response to this ORFF DNA vaccine. The results indicated that mRNA for IFN-gamma was significantly induced in immunized mice. No significant change in IL-4 mRNA expression was observed in mice immunized with ORFF DNA vaccine versus mice immunized with control plasmid. Thus, DNA immunization may offer an attractive alternative strategy against leishmaniasis.
Copyright 2002 Elsevier Science Ltd.
Similar articles
-
Leishmaniasis: current status of vaccine development.Curr Mol Med. 2004 Sep;4(6):667-79. doi: 10.2174/1566524043360203. Curr Mol Med. 2004. PMID: 15357215 Review.
-
Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani.J Immunol. 2009 Dec 15;183(12):7719-31. doi: 10.4049/jimmunol.0900132. J Immunol. 2009. PMID: 19933862
-
Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.J Immunol. 2000 Dec 15;165(12):7064-71. doi: 10.4049/jimmunol.165.12.7064. J Immunol. 2000. PMID: 11120835
-
Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.Infect Immun. 2001 Aug;69(8):4719-25. doi: 10.1128/IAI.69.8.4719-4725.2001. Infect Immun. 2001. PMID: 11447143 Free PMC article.
-
Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis.Curr Mol Med. 2004 Sep;4(6):697-709. doi: 10.2174/1566524043360212. Curr Mol Med. 2004. PMID: 15357218 Review.
Cited by
-
Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.PLoS One. 2009 Dec 2;4(12):e7880. doi: 10.1371/journal.pone.0007880. PLoS One. 2009. PMID: 19956549 Free PMC article.
-
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.Front Immunol. 2014 Aug 22;5:380. doi: 10.3389/fimmu.2014.00380. eCollection 2014. Front Immunol. 2014. PMID: 25202307 Free PMC article. Review.
-
Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments.Vaccines (Basel). 2019 Oct 18;7(4):156. doi: 10.3390/vaccines7040156. Vaccines (Basel). 2019. PMID: 31635276 Free PMC article. Review.
-
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.Clin Transl Immunology. 2015 Apr 10;4(4):e35. doi: 10.1038/cti.2015.6. eCollection 2015 Apr. Clin Transl Immunology. 2015. PMID: 26175894 Free PMC article.
-
Development of Vaccines against Visceral Leishmaniasis.J Trop Med. 2012;2012:892817. doi: 10.1155/2012/892817. Epub 2011 Sep 5. J Trop Med. 2012. PMID: 21912561 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical